Advanced Detection Excellims specializes in high performance ion mobility spectrometry (HPIMS) and HPIMS-MS, with the world’s first ESI-HPIMS systems for liquids, offering chromatography-like separation with simultaneous detection. This positions them well to upsell integrated HPIMS-MS workflows to labs needing fast, high-resolution analysis across liquids, solids, and gases.

Pharma and Safety Focus Key application areas include Chemical & Pharmaceutical Manufacturing and Food & Drug Safety, plus Academic Research. Potential sales opportunities exist in pharma process analytics, GMP/11 CFR 21 validation–ready software, and compliance-driven laboratories seeking rapid, accurate analytics for quality control and molecular characterization.

Software & Compliance Recent software advancements include a 21 CFR Part 11 compliant package, signaling readiness for regulated environments. This opens doors for selling to pharmaceutical manufacturers and contract research organizations requiring validated electronic records and audit trails.

Leadership & Growth New executive hires in 2020 (COO and VP of Sales) alongside a notable revenue range of $10M–$25M suggest a growth-focused, customer-facing sales strategy. There is potential for channel expansion, strategic partnerships, and targeted outreach to scale adoption in research labs and industry labs.

Global Reach With a global value proposition in industry and research and a diverse customer base, opportunities exist to promote cross-sector deployments, including government and academic institutions, by highlighting rapid deployment, flexible sample handling, and multi-modal detection capabilities to meet varying regulatory and budget constraints.